Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY: RMD )

214.44 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 400
Open 214.44
Bid (Size) 212.00 (1)
Ask (Size) 230.00 (1)
Prev. Close 214.44
Today's Range 214.44 - 214.44
52wk Range 179.00 - 263.05
Shares Outstanding 146,234,244
Dividend Yield 0.99%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which S&P500 stocks are moving after the closing bell on Wednesday?
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top S&P500 gainers and losers in today's after-hours session. 
Via Chartmill
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-6.14%
-6.14%
1 Month
-3.80%
-3.80%
3 Month
-13.30%
-13.30%
6 Month
-9.67%
-9.67%
1 Year
+16.40%
+16.40%

More News

Read More
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
From Resmed, Inc.
Via GlobeNewswire
Earnings Scheduled For April 23, 2025
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss ResMed Stock
Via Benzinga
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Via Benzinga
Topics Government
Exposures Political
A Look Ahead: ResMed's Earnings Forecast
Via Benzinga
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Resmed Names Salli Schwartz as Chief Investor Relations Officer
From Resmed, Inc.
Via GlobeNewswire
Assessing ResMed: Insights From 5 Financial Analysts
Via Benzinga
Why RESMED INC (NYSE:RMD) is a Top Pick for Dividend Investors.
Via Chartmill
Which S&P500 stocks are gapping on Tuesday?
Via Chartmill
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
From Resmed, Inc.
Via GlobeNewswire
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
From Resmed, Inc.
Via GlobeNewswire
Why RESMED INC (NYSE:RMD) Deserves Consideration as a Quality Investment.
Via Chartmill
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
From Resmed, Inc.
Via GlobeNewswire
Tempted To Dump Stock? Consider Shifting To Low Vol Stocks / ETFs Instead
Via Talk Markets
Topics ETFs Stocks / Equities
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
From Resmed, Inc.
Via GlobeNewswire
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top S&P500 movers in Monday's session
Via Chartmill
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
Via Investor's Business Daily
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.